rs374003036
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_017636.4(TRPM4):c.2534C>T(p.Pro845Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000869 in 1,553,146 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_017636.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRPM4 | NM_017636.4 | c.2534C>T | p.Pro845Leu | missense_variant | 17/25 | ENST00000252826.10 | NP_060106.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRPM4 | ENST00000252826.10 | c.2534C>T | p.Pro845Leu | missense_variant | 17/25 | 1 | NM_017636.4 | ENSP00000252826.4 |
Frequencies
GnomAD3 genomes AF: 0.000526 AC: 80AN: 152212Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000106 AC: 17AN: 160580Hom.: 0 AF XY: 0.0000343 AC XY: 3AN XY: 87586
GnomAD4 exome AF: 0.0000393 AC: 55AN: 1400816Hom.: 0 Cov.: 32 AF XY: 0.0000289 AC XY: 20AN XY: 693080
GnomAD4 genome AF: 0.000525 AC: 80AN: 152330Hom.: 0 Cov.: 31 AF XY: 0.000524 AC XY: 39AN XY: 74484
ClinVar
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 18, 2019 | - - |
Progressive familial heart block type IB Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 10, 2022 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 04, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at